Fundsmith LLP’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-278,393
Closed -$43.6M 42
2023
Q4
$43.6M Buy
278,393
+4,015
+1% +$616K 0.18% 37
2023
Q3
$42.7M Buy
274,378
+514
+0.2% +$84.8K 0.19% 34
2023
Q2
$45.3M Sell
273,864
-3,600
-1% -$581K 0.19% 36
2023
Q1
$43M Buy
277,464
+1,667
+0.6% +$269K 0.19% 35
2022
Q4
$48.7M Buy
275,797
+950
+0.3% +$164K 0.22% 34
2022
Q3
$44.9M Buy
274,847
+1,393
+0.5% +$236K 0.21% 36
2022
Q2
$48.5M Buy
273,454
+31,019
+13% +$5.53M 0.21% 34
2022
Q1
$43M Sell
242,435
-6,976,763
-97% -$1.19B 0.15% 38
2021
Q4
$1.23B Buy
7,219,198
+15,629
+0.2% +$2.56M 3.01% 17
2021
Q3
$1.16B Buy
7,203,569
+47,863
+0.7% +$8.17M 3.22% 17
2021
Q2
$1.18B Buy
7,155,706
+514,862
+8% +$85.2M 3.27% 16
2021
Q1
$1.09B Buy
6,640,844
+248,335
+4% +$40.2M 3.47% 15
2020
Q4
$1.01B Sell
6,392,509
-19,101
-0.3% -$2.82M 3.33% 17
2020
Q3
$955M Buy
6,411,610
+6,119
+0.1% +$905K 3.73% 15
2020
Q2
$901M Buy
6,405,491
+1,025,710
+19% +$149M 3.93% 14
2020
Q1
$705M Sell
5,379,781
-683,618
-11% -$97M 3.97% 15
2019
Q4
$884M Buy
6,063,399
+106,578
+2% +$14.5M 4.18% 15
2019
Q3
$771M Buy
5,956,821
+556,690
+10% +$73.3M 3.94% 15
2019
Q2
$752M Buy
5,400,131
+800,396
+17% +$111M 3.92% 15
2019
Q1
$643M Buy
4,599,735
+18,533
+0.4% +$2.48M 3.65% 16
2018
Q4
$633M Hold
4,581,202
4.02% 15
2018
Q3
$633M Buy
4,581,202
+25,716
+0.6% +$3.42M 4.25% 15
2018
Q2
$553M Buy
4,555,486
+228,175
+5% +$28.5M 4.11% 15
2018
Q1
$555M Sell
4,327,311
-4,545
-0.1% -$614K 4.57% 15
2017
Q4
$605M Sell
4,331,856
-42,335
-1% -$5.9M 5.19% 13
2017
Q3
$566M Buy
4,374,191
+295,714
+7% +$39.2M 5.48% 10
2017
Q2
$540M Sell
4,078,477
-25,596
-0.6% -$3.27M 5.66% 9
2017
Q1
$511M Buy
4,104,073
+681
+0% +$81.4K 5.94% 10
2016
Q4
$474M Buy
4,103,392
+120,074
+3% +$13.9M 6.24% 8
2016
Q3
$471M Buy
3,983,318
+278,625
+8% +$33.8M 6.43% 10
2016
Q2
$449M Buy
3,704,693
+719,532
+24% +$81.8M 7.12% 5
2016
Q1
$323M Buy
2,985,161
+145,133
+5% +$15M 6.95% 6
2015
Q4
$292M Buy
2,840,028
+143,858
+5% +$14.5M 7.33% 7
2015
Q3
$252M Buy
2,696,170
+383,301
+17% +$37.1M 7.68% 6
2015
Q2
$225M Buy
2,312,869
+410,766
+22% +$41.1M 7.09% 8
2015
Q1
$190M Buy
1,902,103
+272,120
+17% +$27.7M 6.15% 10
2014
Q4
$170M Buy
1,629,983
+195,665
+14% +$20.6M 6.08% 9
2014
Q3
$153M Buy
1,434,318
+130,933
+10% +$13.6M 6.54% 8
2014
Q2
$136M Buy
1,303,385
+150,517
+13% +$15.2M 6.29% 8
2014
Q1
$113M Buy
1,152,868
+112,077
+11% +$10.4M 5.94% 11
2013
Q4
$95.3M Buy
1,040,791
+2,162
+0.2% +$199K 5.92% 11
2013
Q3
$90M Hold
1,038,629
5.99% 10
2013
Q2
$89.2M Buy
+1,038,629
New +$88.1M 6.27% 9

Other funds holding JNJ

Fundsmith LLP's JNJ Position: Q1 2024 in Review

Fundsmith LLP sold out of Johnson & Johnson (JNJ) in Q1 2024, closing a stake of 278,393 shares — an estimated $43.6M sold.

Fundsmith LLP first reported a position in JNJ in Q2 2013 and held it in 43 quarters. The position peaked at $1.23B in Q4 2021. 3,850 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Fundsmith LLP reported no remaining Johnson & Johnson position as of Q1 2024 after selling out during the quarter.
  • Fundsmith LLP sold 278,393 Johnson & Johnson shares in Q1 2024, an estimated $43.6M.
  • Fundsmith LLP first reported a position in Johnson & Johnson in Q2 2013 and held it in 43 quarters.
  • Fundsmith LLP's Johnson & Johnson position peaked at $1.23B in Q4 2021.
  • 3,850 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Fundsmith LLP's 13F filing for Q1 2024, filed 15 May 2024.